| Literature DB >> 35449452 |
Shiro Koizume1,2, Tomoko Takahashi3, Yoshiyasu Nakamura3, Mitsuyo Yoshihara3, Yukihide Ota3,4, Shinya Sato3,5, Hiroko Tadokoro3, Tomoyuki Yokose5, Hisamori Kato6, Etsuko Miyagi4, Yohei Miyagi7,8.
1. Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, 241-8515, Japan. skoizume@gancen.asahi.yokohama.jp.
2. Department of Pathology, Kanagawa Cancer Center Hospital, Yokohama, 241-8515, Japan. skoizume@gancen.asahi.yokohama.jp.
3. Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, 241-8515, Japan.
4. Department of Obstetrics, Gynecology, and Molecular Reproductive Science, Yokohama City University, Graduate School of Medicine, Yokohama, 236-0004, Japan.
5. Department of Pathology, Kanagawa Cancer Center Hospital, Yokohama, 241-8515, Japan.
6. Department of Gynecology, Kanagawa Cancer Center Hospital, Yokohama, 241-8515, Japan.
7. Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, 241-8515, Japan. miyagi@gancen.asahi.yokohama.jp.
8. Department of Pathology, Kanagawa Cancer Center Hospital, Yokohama, 241-8515, Japan. miyagi@gancen.asahi.yokohama.jp.
Abstract
Entities:
Mesh:
Adenocarcinoma, Clear Cell/genetics
Adenocarcinoma, Clear Cell/metabolism
Autophagy/genetics
Fatty Acids/metabolism
Female
Humans
Hypoxia
Intercellular Adhesion Molecule-1/genetics
Intercellular Adhesion Molecule-1/metabolism
Ovarian Neoplasms/genetics
Ovarian Neoplasms/metabolism
Prognosis
Substances:
Fatty Acids
ICAM1 protein, human
Intercellular Adhesion Molecule-1
Year: 2022 PMID: 35449452 PMCID: PMC9346109 DOI: 10.1038/s41416-022-01808-4
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 9.075